help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on March 20, 2007
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-1935
A more recent version of this article appeared on June 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
92/6/2232    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seto-Young, D.
Right arrow Articles by Poretsky, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seto-Young, D.
Right arrow Articles by Poretsky, L.

Submitted on September 5, 2006
Accepted on March 12, 2007

Interactions among Peroxisome Proliferator Activated Receptor-{gamma}, Insulin Signaling Pathways and Steroidogenic Acute Regulatory Protein in Human Ovarian Cells

Donna Seto-Young, Dimiter Avtanski, Marina Strizhevsky, Grishma Parikh, Parini Patel, Julia Kaplun, Kevin Holcomb, Zev Rosenwaks, and Leonid Poretsky*

G. J Friedman Diabetes Institute and the Division of Endocrinology, Department of Medicine (D.S.-Y., D.A., M.S., G.P., P.P., J.K., L. P.), Department of Obstetrics and Gynecology (K. H.), Beth Israel Medical Center and Albert Einstein College of Medicine, New York, New York 10003; Institute of Biology and Immunology of Reproduction (D.A.), Bulgarian Academy of Sciences, Sofia, Bulgaria, 1113; and Center for Reproductive Medicine and Infertility (Z.R.), Weill Medical College of Cornell University, New York, New York, 10021

* To whom correspondence should be addressed. E-mail: lporetsk{at}bethisraelny.org.

Context and Objective: Peroxisome proliferator activated receptor-{gamma} (PPAR-{gamma}) agonists thiazolidinediones (TZDs) are thought to ameliorate hyperandrogenism in polycystic ovary syndrome by reducing hyperinsulinemia. TZDs, however, also exhibit direct effects in the human ovary. We examined interactions among PPAR-{gamma}, insulin signaling pathways and steroidogenic acute regulatory (StAR) protein in human ovarian cells.

Materials and Methods: Mixed human ovarian tissue culture which contained granulosa, theca and stromal cells, and a culture of purified granulosa cells obtained during in-vitro fertilization, were established as previously described. Cells were cultured in the presence or absence of insulin, with or without 25 µM or 50 µM of rosiglitazone or pioglitazone. Expression of PPAR-{gamma}, insulin receptor or IRS-1 in both cell systems and of the StAR protein in granulosa cells was measured using immunoprecipitation and immunoblotting.

Results: Rosiglitazone stimulated expression of PPAR-{gamma}, insulin receptor {alpha}- and {beta}-subunits and IRS-1 up to 168% (p<0.05), 679% (p<0.006), 290% (p<0.037) and 323% (p<0.01) of baseline, respectively. Pioglitazone stimulated expression of PPAR-{gamma}, insulin receptor {alpha}- and {beta}-subunits and IRS-1 up to 222% (p<0.01), 362% (p<0.001), 402% (p<0.029) and 492% (p<0.03), respectively. Insulin alone stimulated expression of PPAR-{gamma}, {alpha}-subunit and {beta}-subunit of insulin receptor and IRS-1 up to 174% (p<0.001), 692% (p<0.014), 275% (p<0.024) and 431% (p<0.01), respectively. In purified granulosa cell culture, rosiglitazone stimulated expression of StAR protein up to 540% (p<0.007) and pioglitazone stimulated expression of StAR protein up to 670% (p<0.007). Insulin alone stimulated expression of StAR protein up to 600% (p<0.012).

Conclusions: Insulin and TZDs independently stimulate expression of PPAR-{gamma}, insulin receptor, IRS-1 and StAR protein in human ovarian cells. Thus, PPAR-{gamma}, insulin receptor with its signaling pathways, and StAR protein constitute a novel human ovarian regulatory system with complex interactions among its components.




This article has been cited by other articles:


Home page
EndocrinologyHome page
C. E. Minge, B. D. Bennett, R. J. Norman, and R. L. Robker
Peroxisome Proliferator-Activated Receptor-{gamma} Agonist Rosiglitazone Reverses the Adverse Effects of Diet-Induced Obesity on Oocyte Quality
Endocrinology, May 1, 2008; 149(5): 2646 - 2656.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society